Author

Kautz A

6 مارس 2018
التهاب الكبد الوبائي سي: بداية النهاية - العناصر الرئيسية للاستراتيجيات الأوروبية والوطنية الناجحة للقضاء على التهاب الكبد الفيروسي في أوروبا
Summary Hepatitis C virus (HCV) infection is a major public health problem in the European Union (EU). An estimated 5.6 million Europeans are chronically infected with a wide range of variation in prevalence across European Union countries. Although HCV continues to spread as a largely “silent pandemic,” its elimination is made possible through the availability […]

Read More
5 مايو 2014
استراتيجيات إدارة عبء مرض فيروس التهاب الكبد الوبائي سي
Summary The number of hepatitis C virus (HCV) infections is projected to decline while those with advanced liver disease will increase. A modeling approach was used to forecast two treatment scenarios: (i) the impact of increased treatment efficacy while keeping the number of treated patients constant and (ii) increasing efficacy and treatment rate. This analysis […]

Read More
5 مايو 2014
عبء المرض الحالي والمستقبلي لعدوى فيروس التهاب الكبد الوبائي سي (HCV) مع نموذج العلاج الحالي
Summary The disease burden of hepatitis C virus (HCV) is expected to increase as the infected population ages. A modeling approach was used to estimate the total number of viremic infections, diagnosed, treated and new infections in 2013. In addition, the model was used to estimate the change in the total number of HCV infections, […]

Read More
5 مايو 2014
الوبائيات التاريخية لفيروس التهاب الكبد الوبائي سي (HCV) في بلدان مختارة
Summary Chronic infection with hepatitis C virus (HCV) is a leading indicator for liver disease. New treatment options are becoming available, and there is a need to characterize the epidemiology and disease burden of HCV. Data for prevalence, viremia, genotype, diagnosis and treatment were obtained through literature searches and expert consensus for 16 countries. For […]

Read More